These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 33982266)

  • 21. Nontuberculous Mycobacterial Infections in Cystic Fibrosis.
    Martiniano SL; Nick JA; Daley CL
    Clin Chest Med; 2016 Mar; 37(1):83-96. PubMed ID: 26857770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Shifting paradigms of nontuberculous mycobacteria in cystic fibrosis.
    Qvist T; Pressler T; Høiby N; Katzenstein TL
    Respir Res; 2014 Apr; 15(1):41. PubMed ID: 24725650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced risk of nontuberculous mycobacteria in cystic fibrosis adults receiving long-term azithromycin.
    Coolen N; Morand P; Martin C; Hubert D; Kanaan R; Chapron J; Honoré I; Dusser D; Audureau E; Veziris N; Burgel PR
    J Cyst Fibros; 2015 Sep; 14(5):594-9. PubMed ID: 25735458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increasing nontuberculous mycobacteria infection in cystic fibrosis.
    Bar-On O; Mussaffi H; Mei-Zahav M; Prais D; Steuer G; Stafler P; Hananya S; Blau H
    J Cyst Fibros; 2015 Jan; 14(1):53-62. PubMed ID: 24917112
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Nontuberculous mycobacteria in cystic fibrosis].
    Le Bourgeois M; Sermet-Gaudelus I; Catherinot E; Gaillard JL
    Arch Pediatr; 2005 Aug; 12 Suppl 2():S117-21. PubMed ID: 16129322
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Administration and monitoring of clofazimine for NTM infections in children with and without cystic fibrosis.
    Cameron LH; Peloquin CA; Hiatt P; Mann M; Starke JR; Faircloth J; McNeil JC; Patel A; Ruiz F
    J Cyst Fibros; 2022 Mar; 21(2):348-352. PubMed ID: 34479810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis.
    Waters V; Ratjen F
    Cochrane Database Syst Rev; 2016 Dec; 12(12):CD010004. PubMed ID: 28000919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-tuberculous mycobacteria disease pre-lung transplantation: A systematic review of the treatment regimens and duration pre- and post-transplant.
    van Gemert JP; Ravensbergen SJ; Verschuuren EAM; Kerstjens HAM; Willemse BWM; van Ingen J; Hoefsloot W; Gan T; Akkerman OW
    Transplant Rev (Orlando); 2023 Dec; 37(4):100800. PubMed ID: 37832509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mycobacterium avium and Mycobacterium abscessus complex target distinct cystic fibrosis patient subpopulations.
    Catherinot E; Roux AL; Vibet MA; Bellis G; Ravilly S; Lemonnier L; Le Roux E; Bernède-Bauduin C; Le Bourgeois M; Herrmann JL; Guillemot D; Gaillard JL;
    J Cyst Fibros; 2013 Jan; 12(1):74-80. PubMed ID: 22857820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High incidence of non-tuberculous mycobacteria-positive cultures among adolescent with cystic fibrosis.
    Cavalli Z; Reynaud Q; Bricca R; Nove-Josserand R; Durupt S; Reix P; Perceval M; de Montclos MP; Lina G; Durieu I
    J Cyst Fibros; 2017 Sep; 16(5):579-584. PubMed ID: 28202251
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nontuberculous mycobacteria in the setting of cystic fibrosis.
    Ebert DL; Olivier KN
    Clin Chest Med; 2002 Sep; 23(3):655-63. PubMed ID: 12371001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activities of Dual Combinations of Antibiotics Against Multidrug-Resistant Nontuberculous Mycobacteria Recovered from Patients with Cystic Fibrosis.
    Schwartz M; Fisher S; Story-Roller E; Lamichhane G; Parrish N
    Microb Drug Resist; 2018 Oct; 24(8):1191-1197. PubMed ID: 29368988
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disease caused by non-tuberculous mycobacteria in children with cystic fibrosis.
    Lu M; Saddi V; Britton PN; Selvadurai H; Robinson PD; Pandit C; Marais BJ; Fitzgerald DA
    Paediatr Respir Rev; 2019 Feb; 29():42-52. PubMed ID: 30473423
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The frequency and related factors of non-tuberculosis mycobacteria infections among patients with cystic fibrosis.
    Ademhan Tural D; Emiralioglu N; Ozsezen B; Saribas Z; Ozcan N; Alp A; Sunman B; Hizal M; Eryilmaz Polat S; Yalcin E; Dogru D; Ozcelik U; Kiper N
    Pediatr Int; 2021 Nov; 63(11):1369-1375. PubMed ID: 33682254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibiotic treatment for nontuberculous mycobacterial lung disease.
    Kang YA; Koh WJ
    Expert Rev Respir Med; 2016; 10(5):557-68. PubMed ID: 26967761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis.
    Waters V; Ratjen F
    Cochrane Database Syst Rev; 2014 Dec; (12):CD010004. PubMed ID: 25470304
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis.
    Waters V; Ratjen F
    Cochrane Database Syst Rev; 2012 Dec; 12():CD010004. PubMed ID: 23235684
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of slowly growing mycobacteria.
    Philley JV; Griffith DE
    Clin Chest Med; 2015 Mar; 36(1):79-90. PubMed ID: 25676521
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduced Sphingosine in Cystic Fibrosis Increases Susceptibility to
    Schnitker F; Liu Y; Keitsch S; Soddemann M; Verhasselt HL; Kehrmann J; Grassmé H; Kamler M; Gulbins E; Wu Y
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nontuberculous mycobacteria in patients with cystic fibrosis.
    Leung JM; Olivier KN
    Semin Respir Crit Care Med; 2013 Feb; 34(1):124-34. PubMed ID: 23460012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.